[Frey syndrome: diagnosis and treatment].
Observed lately increased of the Lucie Frey's syndrom occurance is related to advanced frequency of the parotid gland surgery, especially because of neoplasmic lesions of the gland. Symptoms which follow partial or total parotidectomy are very bothersome for patients and unfortunately they strengthening with a lapse of a time. For applied pharmacotherapy outcomes are in fact dubious. In this light the recently applicated clostridium botulinum toxin of type A deserves of special attention as patient therapeutic agent for Frey's syndrome because of very promising results which can last for several months and even years. At first discussing the anatomopatholophysiology as well as diagnostic tests. The authors present their own experience as well as results obtained in application of the botulin toxin for therapy of the Lucie Frey syndrome.
Budziński
R
R
Oddział Otolaryngologii Okregowego Szpitala Kolejowego w Krakowie.
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D013547:Sweating, Gustatory / Q000188:drug therapy* / Q000473:pathology*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A